Asia Business Gazette: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Asia Business Gazette.

Press releases published on September 8, 2026

Sep. 8, 2026

Atea Pharmaceuticals to Present at the Morgan Stanley 24th Annual Global Healthcare Conference

Indeterminate GlobeNewswire

Sep. 8, 2026

G3 Goldfields Provides Update on Listing

Indeterminate GlobeNewswire

Sep. 8, 2026

CalciMedica to Participate in the H.C. Wainwright 28th Annual Global Investment Conference

Indeterminate GlobeNewswire

Sep. 8, 2026

Sernova and Seraxis Enter Definitive Merger Agreement to Create a Differentiated Type 1 Diabetes Islet Cell-Replacement Biotech Company, BetaNova Biotherapeutics

Indeterminate GlobeNewswire

Sep. 8, 2026

Erasca to Present at the Morgan Stanley 24th Annual Global Healthcare Conference

Indeterminate GlobeNewswire

Sep. 8, 2026

BrainChild Bio Initiates Pivotal Phase 2 Trial for BCB-276 CAR T cell Therapy for DIPG, a Deadly Pediatric Brain Cancer

Indeterminate GlobeNewswire

Sep. 8, 2026

Cartesian Therapeutics Announces New Employment Inducement Grants

Indeterminate GlobeNewswire

Sep. 8, 2026

Tonix Pharmaceuticals Promotes Thomas Englese, MBA, to Chief Commercial Officer

Indeterminate GlobeNewswire

Sep. 8, 2026

BrainChild Bio Closes $116 Million Series A Financing

Indeterminate GlobeNewswire

Sep. 8, 2026

NetraMark Appoints Former Global Atlantic Investment Office President and Scotiabank U.S. CEO Kevin Felix as Strategic Advisor

Indeterminate GlobeNewswire

Sep. 8, 2026

Lightbridge Letter to Shareholders Outlines Expedited Pathway to Bring Lightbridge Fuel™ to Commercial Reactors

Indeterminate GlobeNewswire

Sep. 8, 2026

NovaBridge Appoints Martin Dewhurst to Board of Directors as an Independent Director

Indeterminate GlobeNewswire

Sep. 8, 2026

Kura Oncology Appoints Jennifer Fulk as Chief Financial Officer

Indeterminate GlobeNewswire

Sep. 8, 2026

Newron Reports Subscription for EUR 5.5 Million of Shares by Investor Group as Part of Up to EUR 38 Million Total Financing to Advance Phase 3 Evenamide Program

Indeterminate GlobeNewswire

Sep. 8, 2026

DraftKings Extends Agreement with IC360 to Enhance Integrity Monitoring and Combat Athlete Harassment Across Sportsbook and Prediction Market Platforms

Indeterminate GlobeNewswire

Sep. 8, 2026

Editas Medicine Appoints Dan Ory, M.D., as Chief Medical Officer

Indeterminate GlobeNewswire

Sep. 8, 2026

Nkarta to Present Initial Autoimmune Clinical Data for NKX019 at American College of Rheumatology (ACR) Convergence 2026

Indeterminate GlobeNewswire

Sep. 8, 2026

Lahontan Strengthens Technical, Engineering, and Business Development Team

Indeterminate GlobeNewswire

Sep. 8, 2026

Phoenix Metals Receives Amended Exploration Permit and Accelerates Phase 1 Drill Program at Greenwood

Indeterminate GlobeNewswire

Sep. 8, 2026

Silicon Motion to Attend Upcoming Investor Conferences

Indeterminate GlobeNewswire